Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Variables and values used in the sensitivity analyses

From: Economic evaluation of participatory learning and action with women’s groups facilitated by Accredited Social Health Activists to improve birth outcomes in rural eastern India

Variable

Lower limit

Base-case scenario

Upper limit

Reasoning

Changing discount rate (base case 3% both costs and outcomes)

WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003.

 

Costs 0%, life-years 0%

3%

Costs 6%, life-years 3%

Exchange rate (USD to INR)

50

68.07

 

Observed variation during the trial period

Number of neo-natal deaths averted

18

50

76

The upper and lower limits of the 95% confidence interval of odds ratio of reduction in neo-natal mortality

Life-expectancy at birth (years)

68.5a

86

 

Consistent with standard practice in economic assessment to take standard expected life expectancy. GBD-2010

  1. a Life expectancy at birth 2016 in India (http://www.indexmundi.com/india/life_expectancy_at_birth.html)
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us